Chiang Mai University-Clinical Trial Unit (CMU-CTU)
8th floor, Chaloem Phra Phrabarami Building, Faculty of Medicine, Chiang Mai University 110 Intawaroros Road, Si Phum, Muang, Chiang Mai, Thailand 50200
Clinical Research Center (CRC) Ramathibodi Hospital, Faculty of Medicine Ramathibodi Hospital, Mahidol University
3rd floor Room 310, Office of Academic Research and Innovation, Research and Services Building, Faculty of Medicine Ramathibodi Hospital Mahidol University 270 Rama VI Road, Ratchathewi, Bangkok, Thailand 10400
Siriraj Institute of Clinical Research (SICRES), Siriraj Medical Research Center (SiMR), Faculty of Medicine Siriraj Hospital, Mahidol University
Siriraj Institute of Clinical Research, 10th floor, Siriraj Medical Research Center (SiMR), Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Siriraj, Bangkok Noi, Bangkok, Thailand 10700
Prince of Songkla University, Clinical Research Center
Clinical Research Center, 4th Floor 100 years Building, Songklanagarind Hospital 15 Karnjanavanich Rd., Kho Hong Yai, Hat Yai, Songkhla, Thailand 90110
How confident do you feel with where the company is going?
We will begin in this chapter by dealing with some general quantum mechanical ideas. Some of the statements will be quite precise, others only partially precise. It will be hard to tell you as we go along which is which, but by the time you have finished the rest of the book, you will understand in looking back which parts hold up and which parts were only explained roughly.
How confident do you feel with where the company is going?
We will begin in this chapter by dealing with some general quantum mechanical ideas. Some of the statements will be quite precise, others only partially precise. It will be hard to tell you as we go along which is which, but by the time you have finished the rest of the book, you will understand in looking back which parts hold up and which parts were only explained roughly.
How confident do you feel with where the company is going?
We will begin in this chapter by dealing with some general quantum mechanical ideas. Some of the statements will be quite precise, others only partially precise. It will be hard to tell you as we go along which is which, but by the time you have finished the rest of the book, you will understand in looking back which parts hold up and which parts were only explained roughly.
How confident do you feel with where the company is going?
We will begin in this chapter by dealing with some general quantum mechanical ideas. Some of the statements will be quite precise, others only partially precise. It will be hard to tell you as we go along which is which, but by the time you have finished the rest of the book, you will understand in looking back which parts hold up and which parts were only explained roughly.
How confident do you feel with where the company is going?
We will begin in this chapter by dealing with some general quantum mechanical ideas. Some of the statements will be quite precise, others only partially precise. It will be hard to tell you as we go along which is which, but by the time you have finished the rest of the book, you will understand in looking back which parts hold up and which parts were only explained roughly.
How confident do you feel with where the company is going?
We will begin in this chapter by dealing with some general quantum mechanical ideas. Some of the statements will be quite precise, others only partially precise. It will be hard to tell you as we go along which is which, but by the time you have finished the rest of the book, you will understand in looking back which parts hold up and which parts were only explained roughly.
Partner Site Network
Clinixir
A hub for innovative clinical research, collaboration, and cutting-edge science.
Northern
Focused on advanced medical institutions, innovative clinical trials.
Northeastern
Known for community-driven studies with diverse populations.
Central
The hub for large-scale trials and advance data management.
Eastern
Specializes in international collaboration and diverse patient studies.
Southern
Efficient patient recruitment and rapid study execution.
"I am very pleased to update everyone that the First Country Subject has been enrolled by Thailand Team on 11 October 2023 at site THA-764-002! After all from the start up process up to getting the approval, trainings, documentations, we have finally made it. I know this is not easy, So I want to take this opportunity to give thanks to the site, Clinixir and to the AZ Thailand study team for your hard work!"
“Tech Observer would like to thank Clinixir for your close collaboration with the sponsor and us during the recent PY8 application process. Your diligent efforts in supporting the sponsor and coordinating with the sites to obtain the necessary documents for PY8 are commendable. Additionally, Clinixir's attendance for a telephone conference with the sponsor on short notice is highly appreciated. The sponsor is deeply thankful for your dedication and support. Thank you.!”
Peng Chan
Director, Tech Observer Asia Pacific Pte. Ltd.
“I am delighted to hear the news and I extend my heartfelt congratulations to each one of your team for reaching this milestone. It reflects the dedication and hard work put forth through exceptional teamwork. Let us carry forward the momentum, enthusiasm, and collaborative spirit to achieve the upcoming milestones. Great job team.”
Dr. Arun Mohan
Sr. Clinical Project Manager ,Tech Observer Asia Pacific Pte. Ltd.
“We are highly impressed with Clinixir's team, whose professionalism and expertise have greatly contributed to the success of our project.”
Suleeporn Pisitthakarn
Great Eastern Drug Co.,Ltd.
“The Sponsor extends their gratitude to K Purada and the Clinixir CRAs/CTA for their invaluable assistance and dedication in successfully cleaning and locking the ChulaVac006 database for the project's interim analysis as planned on February 16, 2024. Your efforts are greatly appreciated.”
Suttipong Chinkrua
Project Manager, Freelance
“Thank you for your kind support in ensuring the cleaning and locking of the ChulaVac006 interim analysis database as planned. The sponsor greatly appreciates your dedication.
Suttipong Chinkrua
Project Manager, Freelance
Subscribe to Our Monthly Newsletter
Sign up to our monthly newsletter to get the latest news and updates delivered directly in your inbox
